Dynamic changes of immune-related molecules of peripheral blood in patients treated immunotherapy with advanced non-small cell lung cancer
Not Applicable
- Conditions
- Patients diagnosed with advanced non-small cell lung cancer (NSCLC: Non-Small-Cell-Lung-Cancer) scheduled to receive immunotherapy and combined immunotherapy
- Registration Number
- JPRN-UMIN000042885
- Lead Sponsor
- Tohoku Medical and Pharmaceutical University,Tohoku Medical and Pharmaceutical University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Patients having an overlap cancer with activity Patients that an doctor judged to be inappropriate
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method We measured the dynamics of soluble immune checkpoint molecules, and observe clinical effect and observe toxicity, recurrence, and prognosis. Then evaluate their relevance.
- Secondary Outcome Measures
Name Time Method